Clinical Trial: A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects

U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07239973) titled 'A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects' on Nov. 13.

Brief Summary: A Randomized, Double-Blind, Placebo-Controlled, Single/Multiple-dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BGM0504 Tablets Orally Administered in Healthy and Non-diabetic Overweight or Obese Chinese Subjects.

Study Start Date: Oct. 21

Study Type: INTERVENTIONAL

Condition: Healthy Non-diabetic Overweight or Obese

Intervention: DRUG: BGM0504 tablets

Administered p.o.

DRUG: Placebo tablets

Administered p.o.

Recruitment Status: RECRUITING

Sponsor: BrightGene Bio-Medical Techn...